mds - aml - 2020 spring virtual conference: when mds becomes aml - for high-risk mds patients
Published 1 year ago • 225 plays • Length 50:26Download video MP4
Download video MP3
Similar videos
-
49:51
mds - 2020 spring virtual conference: what's in an mds diagnosis?
-
1:16:58
what are my options with high risk mds aml
-
11:49
2022 scientific symposium highlights for patients: treatments for mds and secondary aml
-
55:36
ash 2020: aml secondary to mds - updates for patients
-
1:36
innovations in mds and aml treatment
-
1:00:54
managing higher risk mdl and aml
-
6:37
low-risk mds updates from ash19
-
5:36
david sallman: magrolimab plus azacitidine effective in mds and aml
-
1:01:45
new and emerging therapies for mds
-
1:10:32
mds/mpn/aml session
-
6:50
the role of bmt in treatment-related mds and aml
-
1:27:42
precision medicine in mds and aml
-
7:01
immune based therapies for mds and aml
-
1:04:46
ash 2019 the latest in mds and secondary aml
-
1:50:31
toronto mds patient webinar
-
1:00:07
the therapeutic revolution in management of higher risk mds: a focus on immunotherapy
-
25:41
8th seattle patient conference mds transplant options
-
47:01
advancing the management of mds and aml: novel immune-based approaches
-
4:51
mds webinar clip: what's new in mds: updates from ash18